Aripiprazole in Children and Adolescents With Tourette's Disorder: An Open-Label Safety and Tolerability Study

Journal of Child and Adolescent Psychopharmacology - United States
doi 10.1089/cap.2009.0035
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

Safety and Tolerability of Desvenlafaxine in Children and Adolescents With Major Depressive Disorder

Journal of Child and Adolescent Psychopharmacology
Mental HealthChild HealthPharmacologyPerinatologyPsychiatryPediatrics
2014English

Relative Efficacy of Haloperidol and Pimozide in Children and Adolescents With Tourette's Disorder

American Journal of Psychiatry
PsychiatryMental Health
1997English

Erratum To: Safety and Tolerability of Levomilnacipran ER in Major Depressive Disorder: Results From an Open-Label, 48-Week Extension Study

Clinical Drug Investigation
MedicinePharmacology
2013English

Efficacy, Safety and Tolerability of Escitalopram in Doses Up to 50 Mg in Major Depressive Disorder (MDD): An Open-Label, Pilot Study

BMC Psychiatry
PsychiatryMental Health
2011English

Aripiprazole in Pervasive Developmental Disorder Not Otherwise Specified and Asperger's Disorder: A 14-Week, Prospective, Open-Label Study

Journal of Child and Adolescent Psychopharmacology
Mental HealthChild HealthPharmacologyPerinatologyPsychiatryPediatrics
2009English

Safety and Tolerability of Adjunctive Lacosamide in a Pediatric Population With Focal Seizures-An Open-Label Trial

Seizure : the journal of the British Epilepsy Association
MedicineNeurology
2019English

A Phase 3, Multicenter, Open-Label, 12-Month Extension Safety and Tolerability Trial of Lisdexamfetamine Dimesylate in Adults With Binge Eating Disorder

Journal of Clinical Psychopharmacology
PsychiatryMental HealthPharmacology
2017English

Efficacy and Tolerability of Different Interventions in Children and Adolescents With Attention Deficit Hyperactivity Disorder

Frontiers in Psychiatry
PsychiatryMental Health
2017English

Tolerability and Safety of Novel Half Milliliter Formulation of Glatiramer Acetate for Subcutaneous Injection: An Open-Label, Multicenter, Randomized Comparative Study

Journal of Neurology
Neurology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy